- Home
- DLPN vs CRIS Comparison
DLPN vs CRIS Comparison
Compare DLPN & CRIS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | DLPN | CRIS |
|---|---|---|
| Founded | 1996 | 2000 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Other Consumer Services | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 19.1M | 20.6M |
| IPO Year | 2008 | 2000 |
Fundamental Metrics
Financial Performance| Metric | DLPN | CRIS |
|---|---|---|
| Price | $1.10 | $0.44 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $17.00 |
| AVG Volume (30 Days) | 16.3K | ★ 417.0K |
| Earning Date | 05-15-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 77.87 | ★ 91.57 |
| EPS | ★ N/A | N/A |
| Revenue | ★ $56,699,389.00 | $9,898,000.00 |
| Revenue This Year | $14.73 | $27.10 |
| Revenue Next Year | $7.41 | $67.74 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | 9.70 | ★ 31.50 |
| 52 Week Low | $0.99 | $0.38 |
| 52 Week High | $1.88 | $2.48 |
Technical Indicators
Market Signals| Indicator | DLPN | CRIS |
|---|---|---|
| Relative Strength Index (RSI) | 32.93 | 37.96 |
| Support Level | $1.06 | N/A |
| Resistance Level | $1.67 | $0.57 |
| Average True Range (ATR) | 0.09 | 0.05 |
| MACD | 0.00 | -0.00 |
| Stochastic Oscillator | 28.79 | 23.18 |
Price Performance
Historical ComparisonAbout DLPN Dolphin Entertainment Inc.
Dolphin Entertainment Inc is an independent entertainment marketing and production company. It provides strategic marketing and publicity services to many of the top brands, both individual and corporate, in the motion picture, television, music, gaming, culinary, hospitality, and lifestyle industries. It operates in two reportable segments: Entertainment publicity and marketing and Content production. It generates the majority of its revenue from the Entertainment publicity and marketing segment which provides clients with diversified marketing services, including public relations, entertainment and hospitality content marketing, strategic marketing consulting, and content production of marketing materials.
About CRIS Curis Inc.
Curis Inc is a biotechnology company that develops and commercializes drugs and therapies in the immuno-oncology and precision oncology therapeutic areas. The company targets solid tumors, diffuse large B-cell lymphoma, solid tumors or lymphomas, hematological cancers, and others. Its pipeline products include Fimepinostat, CA-170, CA-4948, CA-327, and Erivedge.